Pandey is in talks with credit arms of Avendus, KKR and Kotak among others to raise about ₹500 crore to finance the proposed buyout of stakes held by British International Investment (BII) and Orbimed, they said.
Related Posts
India launches first ESG framework for healthcare & pharma
Post Views: 41 Aspire Impact and Aspire Circle, supported by…
Q2 healthcare & pharma deals drop to $1.3 billion
Post Views: 43 In Q2 2025, India’s healthcare and pharma sector…
HIV privacy breach at hosp: HC orders govt to pay up 2L
Post Views: 20 The court noted that the mother was…